South Korea's Daesang shifts amino acid focus to pharmaceutical grade after German acquisition

10 Sept 2026
South Korea's Daesang shifts amino acid focus to pharmaceutical grade after German acquisition

The feed-grade lysine producer will make raw material in Korea and purify at AMINO GmbH's plant in Germany, targeting medical and biopharmaceutical markets.

Share:LinkedInX